Trials / Completed
CompletedNCT00484003
A Quality of Life and Safety Study With Pimecrolimus Cream, 1% in Children (Age 2-12 Years) With Atopic Dermatitis
A 3-Month Open Label, National, Quality of Life , and Safety Study With Pimecrolimus Cream, 1% in Children (Age 2-12 Years ) With Atopic Dermatitis
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Novartis · Industry
- Sex
- All
- Age
- 2 Years – 12 Years
- Healthy volunteers
- Not accepted
Summary
The study will evaluate the safety and effect of pimecrolimus cream 1% on quality of life of caregivers of South African children with mild to moderate atopic dermatitis (AD).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pimecrolimus cream 1% |
Timeline
- Start date
- 2004-10-01
- Completion
- 2004-12-01
- First posted
- 2007-06-08
- Last updated
- 2008-02-15
Locations
1 site across 1 country: South Africa
Source: ClinicalTrials.gov record NCT00484003. Inclusion in this directory is not an endorsement.